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Abstract
Background: Malaria transmission is now recognized as a key target for intervention. Evaluation of the Plasmodium
oocyst burden in the midguts of Anopheles spp. is important for many of assays investigating transmission.
However, current assays are very time-consuming, manually demanding and patently subject to observer-observer
variation.
Methods: This report presents the development of a method to rapidly, accurately and consistently determine
oocyst burdens on mosquito midguts using GFP-expressing Plasmodium berghei and a custom-written macro for
ImageJ. The counting macro was optimized and found to be fit-for-purpose by performing gametocyte membrane
feeds with parasite infected blood. Dissected midguts were counted both manually and using the automated
macro, then compared. The optimized settings for the macro were then validated by using it to determine the
transmission blocking efficacies of two anti-malarial compounds - dehydroepiandrosterone sulphate and
lumefantrine, in comparison to manually determined analysis of the same experiment.
Results: Concurrence of manual and macro counts was very high (R2 = 0.973) and reproducible. Estimated
transmission blocking efficacies between manual and automated analysis were highly concordant, indicating that
dehydroepiandrosterone sulphate has little or no transmission blocking potential, whilst lumefantrine strongly
inhibits sporogony.
Conclusion: Recognizing a potential five-fold increase in throughput, the resulting reduction in personnel costs,
and the absence of inter-operator/laboratory variation possible with this approach, this counting macro may be a
benefit to the malaria community.
Background
Plasmodium, the causative agent of malaria has a com-
plex life cycle, requiring both vertebrate and mosquito
hosts. Merozoites invade mammalian red blood cells
(RBCs), wherein they replicate producing schizonts,
which rupture the RBCs releasing daughter merozoites
that are then free to invade other RBCs. With each
such asexual cycle, a small subset of merozoites is
committed to form male or female gametocytes, the
sexual stages of the parasite that are uniquely infec-
tious to mosquitoes [1]. When a mosquito feeds on
blood of an infected host, a drop in temperature and
the presence of a specific mosquito-derived factor,
xanthurenic acid (XA) in the insect’s stomach, within
seconds activate gametocytes to form either male of
female gametes [2]. Following fertilization in the mos-
quito midgut, each zygote generates, ~24 hours later, a
motile ookinete that glides through the digesting blood
meal to the midgut wall. The ookinete passes through
the midgut epithelial cell, reaching the basal lamina
and transforms into the oocyst that grows and devel-
ops over 10-21 days, producing thousands of sporo-
zoites. When the oocysts burst, sporozoites are
released into the mosquito haemolymph where they
migrate to the salivary glands and ducts, ready to
infect another mammalian host [3].
The ‘gold standard’ assay for measuring factors affect-
ing Plasmodium transmission to the mosquito
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(gametocyte to oocyst transition) is to feed groups of
mosquitoes on parasite-infected hosts or infected blood
in artificial membrane feeders (the standard membrane
feed assay - SMFA), and then count the number of
oocysts that develop on the mosquito midgut [4]. This
type of assay has been widely used in various forms
throughout the literature to assess transmission-blocking
compounds [5,6], transmission-blocking vaccines [7-9],
mosquito immune responses [10] and to phenotype
transgenic parasites [11,12]. Whilst it is an extremely
powerful assay, it is very slow, laborious, and subject to
significant observer-observer variation (as observed over
30 years of study, RES, personal observation). Presented
here, is a semi-automated method to greatly increase
the throughput of oocyst counting using GFP-expressing
parasites [13], allowing at least a five-fold increase in
throughput, repeatable and consistent inter-operator
accuracies, thus enabling the larger-scale screening of
transmission blocking interventions to become a more
realistic prospect.
Methods
All work involving laboratory animals was performed in
accordance with the EU regulations ‘EU Directive 86/
609/EEC’ and within the regulations of the United King-
dom Animals (Scientific Procedures) Act 1986.
Parasite maintenance
Female TO mice were treated with phenylhydrazine
three days prior to infection by i.p inoculation with
Plasmodium berghei constitutively expressing GFP
(PbGFPCON - derived from the ANKA line) [13]. To
ensure reproducibility and high infectivity, the parasites
had been passaged between mice no more than eight
times since previously passing through mosquitoes.
After four days of infection, exflagellation was tested by
spotting tail blood into ookinete medium on slides for
15 mins at 20°C. If >5 exflagellation centres were
observed in each of five random fields of view (×40
objective) in which the blood cells form an even mono-
layer, then the mouse was exsanguinated and the
infected blood used in the SMFA.
Compounds
Two anti-malarial compounds - dehydroepiandrosterone
sulphate (DHEA-S) and lumefantrine (LUM), and a
known inhibitor of microgametogenesis and infection
(positive control) - cycloheximide (CH) [14], were
selected for evaluation of the counting macro. DHEA-S
and CH were dissolved in DMSO and LUM was dis-
solved in dimethylformamide (DMF). All were stored
under dry N2 gas as 30 mM stock solutions. Com-
pounds and solvents were provided blind to the experi-
menter and only un-blinded when all experiments were
complete. All compounds were used in the transmis-
sion-blocking assay with no more than a 0.1% final
solvent concentration. 0.1% DMSO or DMF were used
as ‘solvent controls’.
Transmission blocking assay
For each of the three replicate experiments, three
infected mice (see above) were used per assay. They
were anaesthetized, before being rapidly bled by cardiac
puncture and their blood pooled. 500 μl of infected
blood was mixed with each compound to be tested, or
DMSO/DMF as a control, to yield a 10 μM final con-
centration of compound. The infected, drug-treated
blood was then injected into a membrane feeder pre-
warmed to 39°C and offered to overnight-starved Ano-
pheles stephensi (strain SDA 500) mosquitoes in groups
of ~80, which were then allowed to feed on the blood
for 30 min [4]. The next day, mosquitoes that had not
fed were removed and the remaining mosquitoes main-
tained at 19°C and 80%RH, being fed on a fructose/p-
aminobenzoic acid (PABA) solution [4] which was
replenished every 2-3 days. At 7-9 days post feeding,
mosquito midguts were dissected into PBS and the
pooled material fixed in PBS containing 4% paraformal-
dehyde (PFA) for 30 min at room temperature. The guts
were then washed with PBS and stored in PBS in the
dark at 4°C for no more than 3 days before being
counted.
Imaging
Groups of 20 fixed guts were mounted on glass slides
containing a small amount of Vectashield mountant and
a coverslip applied. To facilitate imaging, guts were then
flattened by gently withdrawing some fluid from the
preparation. The slides were observed with a Leica
DMR microscope at ×5 magnification using a Leica
HCX PL FLUOTAR 5×/0.15 lens (to give maximum
optical depth of field combined with adequate spatial
resolution) and guts imaged with a Zeiss AxiocamHR
camera controlled by AxioVision v4.7.2 software. Images
from the same set of feeds were all taken at a resolution
of 1388 × 1040 pixels with the same exposure setting
and guts were all imaged on the same day under the
same conditions. This was done to ensure that there
was minimal variation in fluorescence intensity between
guts due to the degradation of GFP within the oocysts
over the time they were stored.
Results and Discussion
Algorithm
The acquired images of the infected mosquito midguts
can be broken down into two components: 1. Oocysts
that are small (~7-15 pixels/14-30 μm diameter), round
and show high GFP fluorescence; 2. Midgut tissue that
is larger than the oocysts (~600 × 400 pixels/1200 × 800
μm), and has fainter variable and non-uniform yellow-
green autofluorescence. Even though oocysts are
brighter in greyscale than the surrounding midgut
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tissue, it is impossible to reliably separate them by sim-
ply thresholding the image (Figure 1). A low threshold
level will leave traces of the gut in the image and thus
obscure the oocysts (Figure 1b), whereas a high thresh-
old level despite giving a cleaner image, does so at the
cost of losing oocysts with fainter fluorescence (Figure
1c). Also, as midgut background fluorescence varies
between guts, it is impossible to set a standard threshold
level that will apply to all images to give consistency in
analysis.
An automated oocyst counter must therefore be able
to process each image in exactly the same manner to
give reproducible data, therefore, background fluores-
cence must be standardized before an accurate counting
analysis can take place. Experimentally this is very diffi-
cult to achieve and so a macro for ImageJ was devel-
oped that can take any midgut image and process it
with a simple set of standard image transformations that
remove the background tissue fluorescence whilst pre-
serving the oocyst component of the image (Figures 1d
and 1e).
The background fluorescence for each image is mini-
mized by taking a copy of the image, displacing it hori-
zontally by 2 pixels (equivalent to ~1 μm of the
specimen), and then subtracting it from the original
image. Subtracting a copy of the image slightly out of
phase with the original causes large areas of relatively
uniform and weak fluorescence intensity to be cancelled
out (midgut tissue). Small areas (~7-15 pixels diameter)
of bright fluorescence (oocysts), whilst diminishing in
size and intensity remain distinct (Figure 1d). A stan-
dard threshold can then be applied to all images such
that they highlight only the oocysts (Figure 1e). The
standard threshold level that correctly identifies the
oocysts is determined by visually evaluating three repre-
sentative images from the dataset, and then is applied to
all images in the batch of images for a particular group
of feeds. The macro then uses the particle counter func-
tion built-in to ImageJ to count the oocysts it has identi-
fied. The counts generated are then automatically
tabulated, and can be imported into MS Excel or similar
programs for analysis.
Testing - Calibration and accuracy of counting macro
The ImageJ particle counter function used by the count-
ing macro allows the user to specify the minimum parti-
cle size counted. ImageJ defines a particle as an object
of undefined shape with an area measured in pixels
squared (pixels2). For example, objects of 2 × 2 pixels
and 1 × 4 pixels in size are both classified as being 2
pixels2. This value was hypothesized to be critical for
the accuracy of counting. To test this, gut images from
three gametocyte membrane feeds (n = 45, 49 and 51
mosquitoes) were counted by the macro using different
minimum particle sizes. To enable the precision of the
macro counts to be evaluated, the same midgut images
were then recounted and recorded manually by an
experienced trained observer. The observer recorded
each identified oocyst individually and used their own
judgement to discriminate between overlapping oocysts.
It was found that by increasing the minimum particle
size the counter detects from 1 to 8 pixels2, the number
of particles identified by the macro as oocysts decreased
- with 1 pixel2 notably over-counting (by 897.29%) and
8 pixels2 under-counting (65.83% of manual count) (Fig-
ure 2a). To investigate this effect, three images were
randomly selected from the experiments and the fluor-
escence intensity of the individual oocysts present in the
guts (n = 81 oocysts) measured and related to whether
that particular oocyst was counted or not for different
minimum particle sizes (Figure 2b). The macro was
most insensitive to identifying oocysts that had a low
integrated fluorescent intensity (pixel intensity × area).
With increasing minimum particle size, the population
of oocysts with low integrated intensity that were not
identified rose, and also brighter (higher integrated
intensity) oocysts began to be missed (Figures 2b and
2d). The over-count of oocysts produced by a minimum
particle size of 1 or 2 pixels2 (Figure 2a) was found to
be due to false identification of random pixel noise that
was smaller in size than the oocysts (Figures 2c and 2d).
The effect of particle size on calculating the preva-
lence of infection was also tested by imaging 100 unin-
fected guts, and then counting them using the macro
set at the different minimum particle sizes (Table 1).
Due to high false-positive rates a minimum particle size
of 1 or 2 pixels2 gave a prevalence of 100%. At 3 pixels2
this dropped to 9% and by 6 pixels2 had reduced to 2%.
The 2 images that the macro incorrectly identified at
this size contained either abnormally high background
fluorescence in the midgut tissue or contained a single
fluorescent artefact that was the same size and shape as
an oocyst.
As no setting identified oocysts with 100% accuracy, a
minimum particle size of 3 pixels2 (recognizing objects
in the processed image containing 9 pixels or greater)
was selected for use in further experiments with this
material as it most closely balanced out the false posi-
tives and false negatives produced by the macro (Figure
2d).
To check for reproducibility, the oocyst counts for
individual infected midgut images from the three test
gametocyte feeds analysed with a minimum particle size
of 3 pixels2 were plotted on a graph against the corre-
sponding manually determined oocyst count (Figure 3).
Trendlines were fitted to the data (not shown) that gave
R2 values of 0.98, 0.97 and 0.97 respectively (Figure 3),
suggesting that although at this setting the macro
under-counts the number of oocysts present by 13.47%
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Figure 1 Methods of digital processing to identify oocysts on infected mosquito midguts. (a) A microscope image of a mosquito midgut
infected with GFP-expressing parasites can be separated into two distinct components: 1. Small, brightly fluorescent oocysts; 2. Faint, non-
uniform autofluorescent midgut tissue. The graph underneath denotes the pixel intensity along the line Z to Z’. Black asterisks correspond to
oocysts identified manually. It is not possible to accurately separate out the oocyst component of the image by thresholding alone. (b) With a
low threshold level, midgut tissue remains in the image, thus obscuring some oocysts (blue asterisks). (c) A high threshold level eliminates the
background midgut tissue fluorescence, but some fainter fluorescence oocysts are lost also (red asterisks). (d) Applying a 2 pixel horizontal shift
(equivalent to ~1 μm of the specimen) to a copy of the image, followed by a subtraction of the copy from the original image cancels out most
of the midgut background autofluorescence whilst preserving the oocysts. (e) With background fluorescence eliminated, a standard threshold
level can be applied to all gut images that accurately separates the oocysts from midgut tissue.
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Figure 2 Investigating the effects of different minimum particle sizes on the counting accuracy of the macro. It is possible to specify the
minimum particle size counted by the ImageJ particle counter used to identify oocysts in the macro (measured in pixels2). The effect of this on
the ability of the macro to accurately count oocysts was investigated. Three gametocyte membrane feeds were carried out and the parasite-
infected guts were imaged at day 7-9 after feeding (n = 45-51 mosquitoes). (a) The images were analysed by the macro using different
minimum particle sizes and the reported mean oocyst intensity compared to that determined by manual observation of the images. A minimum
particle size of 1 or 2 pixels2 over-counted the mean number of oocysts present per gut. At 3 to 8 pixels2, the macro progressively under-
counted the number of oocysts present. (b) The integrated fluorescence intensity (pixel intensity × oocyst area) of individual oocysts was
measured for three random images from the feeds and it was recorded whether the counting macro had detected or missed each them at
different minimum particle sizes. The macro was found to be less likely to identify oocysts with low integrated fluorescence intensity and that
this effect increased with increasing minimum particle size. (c) Representative image of an oocyst-infected mosquito midgut (red dashed line)
showing the particles identified as oocysts at different minimum particle sizes (white dots). At low minimum particle sizes, many false positives
are generated. (d) A minimum particle size of 3 pixels2 was determined to give the counting macro the best balance between false positives to
false negatives.
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(Figure 2a, 100% minus 86.53), most importantly it is
invariant in the manner that it treats each image.
Implementation - Oocyst counting macro closely
correlates with manual count for two anti-malarial
compounds
10 μM concentrations of CH, DHEA-S, and LUM, and
DMSO or DMF-only carrier controls were added to
parasite infected blood and fed to mosquitoes (n = 28-
58) in triplicate experiments. At day 7-9 the guts were
dissected, imaged and then counted both by the macro
at a minimum particle size of 3 pixels2 and manually.
As the mean oocyst intensities of the solvent control
varied between the three replicates, (for DMSO, between
71.51 and 180.37 oocysts per gut by manual count),
feeds were analysed by expressing the oocyst intensity
for each individual replicate as a percentage of its
respective solvent control, and then taking the mean of
the three replicates (Table 2). This was performed with
the oocyst intensities generated for either the manual or
automated counting methods and then compared. Both
counting methods firmly agreed that DHEA-S was a
very weak inhibitor of sporogony (Manual = 17.79%
reduction in oocyst intensity; Automated = 27.41%
reduction in oocyst intensity), whilst LUM (Manual =
89.15% reduction; Automated = 84.75% reduction)
strongly inhibited sporogony. The prevalence of infec-
tion as determined by the macro count agreed well with
the manually determined prevalence (Table 2), with
LUM showing a statistically significant decrease in pre-
valence (P =< 0.004 unpaired Student’s T-Test). DHEA-
S has been shown to exhibit anti-malarial activity by
inducing phagocytosis of asexual ring stage parasites
[15]. The data presented here suggests that it exerts lit-
tle or no effect on mosquito stage parasites (Table 2).
LUM has been reported to be schizonticidal [16], most
likely exerting its effects through interacting with the
heme detoxification pathway [17] and is most commonly
used today in combination with artemether (Coartem®)
for treating malaria [18]. Interestingly, it exhibits a
strong inhibition of sporogony in P. berghei (Table 2).
The 10 μM concentration we have tested is comparable
to serum levels detected in malaria patients treated with
LUM [19]. As a consequence, it would be prudent to
investigate whether LUM affects P. falciparum in a simi-
lar manner.
By manual count, the earlier observations of Toyé et al
[14] were confirmed in that the protein synthesis inhibi-
tor CH totally inhibited parasite development, and all
guts were free of oocysts. The counting macro nonethe-
less returned a mean oocyst number of 0.20% for CH
compared to the DMSO control, and mean prevalence of
5.61%. When specifically reviewing these images, falsely
reported oocysts were identified as containing oocyst-
sized fluorescent artefacts. This may be controlled
experimentally by imaging and counting a series of unin-
fected guts at the same time as the experimental guts and
taking the calculated prevalence in the uninfected con-
trols as the 0% prevalence baseline for that experiment.
Under the conditions described in this report, research-
ers were able to perform 20 experiments per week on a
sustained basis using the macro. This compares very
favourably with manual counting, which permits only
four experiments per week to be completed on a sus-
tained basis. The counting macro, therefore, as well as
saving time, also reduces the cost of performing SMFAs
and increases the reproducibility of their analysis.
Conclusions
Assays for transmission blocking vaccines/drugs and
phenotypic analyses are vital for the study of Plasmo-
dium development in the mosquito but remain very low
throughput due to the complexity of the experimental
Table 1 Comparison of the effect of minimum particle
size on the calculated prevalence of uninfected guts
Minimum particle size
(pixels2)
1 2 3 4 6 8
Prevalence of 100
uninfected guts
as reported by the macro
(%)
100 100 9 7 2 2
Altering the minimum particle size used to identify oocysts by the counting
macro affected the calculated prevalence of infection. 100 images of
uninfected guts were counted by the macro using different minimum particle
sizes. Due to many false positives, a minimum particle size of 1 to 2 pixels2
gave 100% prevalence. This dropped to 9% for 3 pixels2 and 2% by 6 pixels2.
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Figure 3 Manual counts plotted against automated counts for
three replicate feeds. The oocyst counts for individual guts from
the triplicate gametocyte membrane feeds both counted manually
and by the macro were plotted on a scatter plot. Trendlines were
fitted to the data (not shown) showing that the counts by the
macro in all three experiments were highly consistent (Mean R2 =
0.973).
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set up, and the laborious man-hours of repetitive obser-
vations needed for analysis. The oocyst counting macro
greatly reduces the time and labour needed to analyse
such assays, allowing for greater throughput and mas-
sively increased productivity. Despite slightly under-esti-
mating the oocyst intensity and over-estimating the
prevalence, it gives highly consistent (R2 = 0.97-0.98)
and unbiased counts, well within the range of operator-
operator variability and also never suffers from counting
fatigue. Whilst automated counting systems have been
developed for determining blood-stage parasite burdens
[20,21], currently there are no other published auto-
mated counting systems for evaluating midgut oocyst
burden and so it is anticipated that it will be a valuable
tool.
Although the macro settings were optimized to detect
P. berghei day 7-9 oocysts, recently a P. falciparum
transgenic line constitutively expressing GFP throughout
its life cycle has been generated (Talman AM, Blagbor-
ough AM, Sinden RE: A Plasmodium falciparum strain
expressing GFP throughout the parasite’s life cycle,
PLoS One, in press). Initial testing has shown that the
counting macro is applicable to this parasite line also. It
is anticipated that the counting macro will be easily
adaptable to any technique that renders oocysts a suffi-
ciently contrasting colour to midgut tissue. The count-
ing macro maximizes the throughput of transmission
blocking mosquito-based assays in their current format.
There still remain bottlenecks to further improvements
in throughput, such as dissecting the mosquitoes and
faster imaging. Automated microscopy techniques may
reduce the latter. The former would require a more
drastic reworking of current assay procedures to perhaps
include reporter parasites that can be detected either in
situ in the mosquito, or from crude mosquito extract
(such as luciferase reporter genes). These approaches
however may not give as useful information as they
would assess parasite biomass, which certainly does not
correlate directly with parasite number.
This report demonstrates and validates the utility of
the macro in accurately determining and reporting the
transmission blocking activity of two anti-malarial com-
pounds. With the growing recognition that blocking
parasite transmission to the mosquito is likely to play an
important role in the eradication of malaria [22,23], this
macro is offered as a free download to the research
community [24] under a Creative Commons Attribu-
tion-Non-Commercial-Share Alike licence 2.0.
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Table 2 Comparison of the transmission blocking potential of two anti-malarials determined by manual and
automated counts
Manual count
Intensity as a % of
solvent control (SEM)
Mean prevalence
% (SEM)
Reduction in intensity
% (SEM)
Reduction in prevalence
% (SEM)
DMSO 100 (0) 91.05 (2.95) 0 (0) 0 (0)
DMF 100 (0) 96.90 (0.36) 0 (0) 0 (0)
CH 0 (0) 0 (0) 100 (0) 100 (0)
DHEA-S 82.21 (12.84) 72.78 (11.53) 17.79 (12.84) 10.18 (4.73)
LUM 10.85 (3.35) 69.45 (5.66) 89.15 (3.35) 28.3 (6.01)
Automated count
Mean oocyst intensity as
a % of solvent control (SEM)
Mean prevalence
% (SEM)
Reduction in intensity
% (SEM)
Reduction in
prevalence % (SEM)
DMSO 100 (0) 95.85 (4.87) 0 (0) 0 (0)
DMF 100 (0) 94.60 (1.51) 0 (0) 0 (0)
CH 0.20 (0.13) 5.61 (0.68) 99.80 (0.13) 94.32 (0.62)
DHEA-S 72.59 (3.57) 89.26 (5.25) 27.41 (3.57) 4.37 (4.06)
LUM 15.25 (3.98) 71.95 (8.12) 84.75 (3.98) 24.18 (8.12)
The automated counting macro produced oocyst intensity and prevalence figures closely matching those determined by a manual count. The two anti-malarial
compounds and controls were fed to mosquitoes (n = 28-58) in triplicate experiments. 7-9 days after feeding, the midguts were dissected and imaged before
being counted both manually and by the counting macro. The mean oocyst intensity is expressed as a percentage of the solvent control, and the reduction in
intensity is expressed as 100% minus the mean oocyst intensity. The mean prevalence is expressed as the mean percentage of the number of infected
mosquitoes for each replicate, and reduction in prevalence is calculated using the following formula: (individual replicate prevalence/corresponding control
prevalence) ×100, then taking the mean of the three replicates and subtracting it from 100%. Calculated standard error of the mean in brackets. By manual
count of the parasite-infected midguts, LUM and CH showed a marked inhibition of sporogony. DHEA-S however showed minimal effect on sporogony. The
automated count by the macro concurred well and showed no significant deviation from the manually determined counts. The prevalence of infection recorded
by the counting macro also closely matched the manually determined values.
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